Novartis Gene Therapies, Inc
—Observed value
2Records
2Governments
Nov 21, 2025First seen
Feb 13, 2026Most recent
Records
Public Hearing and Consideration of a Business Development Grant Agreement for Novartis Gene Therapies, Inc. Public Hearing to Consider a Performance-Based Award for Projects Arrowwood & Red Cedar with Novartis Gene Therapies, Inc. (20min)Amounts and company names are read automatically from the official record titles. They are accurate often enough to be useful and not often enough to be relied on blindly — every row links to the source document, which is authoritative.